Health Bulletin 29/October/2022 Roshni Dhar29 Oct 2022 4:54 PM ISTHere are the top health news for the day:NMC warns against Illegal MBBS and other medical courses at Singhania UniversityTaking serious cognizance of...
Pfizer gets CDSCO Panel nod to import, market antimicrobial FDC for additional Indication Dr. Divya Colin10 Oct 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Pfizer has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Biological E gets CDSCO Panel nod to manufacture, market FDC Chlorpheniramine Maleate,Noscapine Oral Liquids Dr. Divya Colin9 Oct 2022 3:23 PM ISTNew Delhi: Pharmaceutical major, Biological E has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard...
Submit CT Protocol, Toxicity Report: CDSCO panel Tells Glenmark on respiratory drug combination Dr. Divya Colin7 Oct 2022 6:00 PM ISTNew Delhi: Directing to conduct Phase III clinical trail and inhalation toxicity study of respiratory fixed dose combination drug Glycopyrronium...
Zydus Healthcare gets CDSCO panel nod to manufacture, market Indacaterol, Budesonide Inhaler Susmita Roy4 Oct 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Zydus Healthcare has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Dosing schedule and duration not defined: CDSCO panel tells Windlas Biotech on antihypertensive FDC Drug Dr. Divya Colin1 Oct 2022 5:00 PM ISTNew Delhi: Citing that dosing schedule and duration was not defined, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Akum Pharmaceutical gets CDSCO Nod to study GERD.FDC drug Dr. Divya Colin17 July 2022 11:15 AM ISTNew Delhi: Drug major, Akum Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Glenmark gets CDSCO Panel nod to study antidiabetic FDC containing Dapagliflozin, Sitagliptin, Metformin Susmita Roy27 Jun 2022 6:15 PM ISTNew Delhi: Granting the waiver of bioequivalence study, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO)...
Glenmark launches FDC asthma medication in India Roshni Dhar17 Jun 2022 6:00 PM ISTGlenmark Pharmaceuticals Limited, an innovation-driven global pharmaceutical company has launched the novel fixed-dose combination (FDC) drug -...
Justify dose of Bilastine: CDSCO Panel tells Glenmark on FDC of Bilastine, Dextromethorphan ,Phenylephrine Syrup Dr. Divya Colin17 May 2022 7:10 PM ISTNew Delhi: Rejecting the pharmaceuticals major Glenmark proposal for bioequivalence (BE) study waiver of fixed dose combination drug Bilastine 3.3mg...
CDSCO panel gives Emcure Pharma waiver on Phase IV CT for Lamivudine plus Dolutegravir Dr. Divya Colin27 April 2022 6:19 PM ISTNew Delhi: Pharmaceutical major, Emcure Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under Central Drug...
Ahead of Linagliptin going off-patent, NPPA fixes retail price of its FDC with Metformin Susmita Roy20 April 2022 6:57 PM ISTNew Delhi: With the popular antidiabetic drug Linagliptin soon expected to go off-patent, the apex drug price regulator, National Pharmaceutical...
